Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Between 2023 and 2045, many key patents will expire, opening the door to generics and forcing originators to diversify protection strategies
Comparison of the gut microbial community between obese and lean peoples using 16 S gene sequencing in a Japanese population
Extending its weight loss portfolio The successful phase 3 trial for Lilly's orforglipron brings the drug one step closer to being approved by the U.S
ACS Appl Mater Interfaces
Bacteria in the gut break down carnitine to trimethylamine N-oxide (TMAO), which can promote arterial disease by increasing cholesterol deposits in the arteries and inflammation
US$ 26.90
US$ 22.87
US$ 29.32
US$ 20.66
